These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Indirect dexamethasone down-regulation of the liver fatty acid-binding protein expression in rat liver. Foucaud L; Niot I; Kanda T; Besnard P Biochim Biophys Acta; 1998 Mar; 1391(2):204-12. PubMed ID: 9555014 [TBL] [Abstract][Full Text] [Related]
24. Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle. Blaak EE; Wagenmakers AJ; Glatz JF; Wolffenbuttel BH; Kemerink GJ; Langenberg CJ; Heidendal GA; Saris WH Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E146-54. PubMed ID: 10893334 [TBL] [Abstract][Full Text] [Related]
25. Regulation of gene expression by fatty acids: special reference to fatty acid-binding protein (FABP). Niot I; Poirier H; Besnard P Biochimie; 1997; 79(2-3):129-33. PubMed ID: 9209709 [TBL] [Abstract][Full Text] [Related]
26. Effect of hydralazine on myocardial plasma membrane fatty acid binding protein (PM-FABP) during diabetes mellitus. Heyliger CE; Powell DM; Skau KA Mol Cell Biochem; 1995 Jul; 148(1):39-44. PubMed ID: 7476932 [TBL] [Abstract][Full Text] [Related]
32. Ferriheme and ferroheme are isosteric inhibitors of fatty acid binding to rat liver fatty acid binding protein. Stewart JM; Slysz GW; Pritting MA; Muller-Eberhard U Biochem Cell Biol; 1996; 74(2):249-55. PubMed ID: 9213434 [TBL] [Abstract][Full Text] [Related]
33. Targeting of drug to the hepatocytes by fatty acids. Influence of the carrier (albumin or galactosylated albumin) on the fate of the fatty acids and their analogs. Charbon V; Latour I; Lambert DM; Buc-Calderon P; Neuvens L; De Keyser JL; Gallez B Pharm Res; 1996 Jan; 13(1):27-31. PubMed ID: 8668674 [TBL] [Abstract][Full Text] [Related]